Setting the standard for international regenerative care.
More than a decade of experience treating patients from around the world.
Living with Parkinson’s, Multiple Sclerosis or another chronic condition can make the future feel small. Horizon is a full year of care for neurological and autoimmune conditions, planned to help you look further ahead.

No two patients share the same story.
Horizon brings the full-year, all-inclusive model of Legacy to patients with neurological and autoimmune conditions. Over one year, your physician combines stem cell therapy with ALTA CELLS™ at a higher cell amount, specialized testing and the supporting therapies your case needs.
Mesenchymal stem cells reduce inflammation and help regulate the immune system, and a year of care gives your team time to measure, adjust and plan the next step with you.
Two patients with the same condition can have very different:
Horizon may be right for you if you:

Live with a neurological or autoimmune condition, such as Parkinson’s, Alzheimer’s, MS or rheumatoid arthritis
Want a full year of care with close monitoring

Prefer one team that arranges testing, treatment and follow-up
Can travel to Panama City for your treatment visits

Understand that results vary and no outcome is promised
Treatment visits in Panama City through the year, planned by your physician.
More ALTA CELLS™ across the year, planned by your physician.
Specialized testing at the start and through the year, chosen for your condition.
A dedicated coordinator, airport transportation and travel insurance coverage in Panama.
A post-treatment plan and progress checks at 1, 3, 6, 9 and 12 months.

Specialized testing maps your condition and biology: inflammation, immune markers, function and more, tracked through the year. Gut health (GI-MAP) and EEG testing are available to include in your program.

We prepare your body for treatment with the nutritional and metabolic support your condition and results call for.

Stem cell therapy and supporting therapies are delivered in Panama City through the year, with about one hour per appointment.

Testing and reviews at 1, 3, 6, 9 and 12 months show what changed, and your physician adjusts the next step of your plan.
More than a decade of experience treating patients from around the world.

A fully integrated medical operation built around advanced regenerative care.
We go deeper than a diagnosis. Your history, labs and goals shape every protocol.
Trusted by patients from 40+ countries.

Wharton’s Jelly stem cells produced entirely in our in-house laboratory, batch by batch.
20+ full-time scientists focused on cell processing, quality, research and innovation.
| Aspect | Animal Serum | Human Platelet Lysate |
|---|---|---|
| Origin | Animal (bovine)-derived | Human (platelet)-derived |
| Xenogenic risk | Bovine proteins and xenogenic components | Completely xeno-free |
| Safety | Higher risk of immune reactions and allergies | No animal components, so a lower risk of reactions to them |
| Consistency | Variable lot-to-lot consistency | High quality & traceable human source |
| Cell quality | Slower proliferation, more senescence | Faster growth, less senescence, better long-term quality |
| Safety profile | Risk of virus, prions and unknown factors | Reduced risk, controlled human source |
| Clinical suitability | Less suited to advanced cell therapies | Well suited to advanced cell therapies |
When a diagnosis changes how you move, speak or remember, every month matters. Stem cells help reduce inflammation and release factors that support the nervous system.
When your immune system attacks your own body, flares and fatigue shape every week. Stem cells help regulate the immune response and reduce inflammation.
Patient stories share individual experiences. Results vary, and no outcome is promised.
Answers about safety, cost and what to expect.
A Personalized Protocol is usually delivered over 3 to 7 days. Horizon spreads care across a full year, with a higher cell amount, repeat testing and visits arranged for you.
Horizon is for neurological and autoimmune conditions, such as Parkinson’s, Alzheimer’s, MS, lupus and rheumatoid arthritis. Our physicians decide suitability after reviewing your records.
Yes. Never stop a prescribed medicine on your own. We coordinate with your neurologist or rheumatologist and share your results with them when you ask us to.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
Horizon is priced as one annual program. You receive your exact price after our medical team reviews your case. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.
Your protocol starts with your case. Through the Regenerative Mapping System, our physicians review your diagnosis, testing and goals, then build a plan around what matters most for you.
Every Personalized Protocol moves through four stages: Diagnostics, Optimization, Treatment and Follow-up, with ALTA CELLS™ produced in our in-house laboratory and a care team that stays in touch after you return home.
A full year of regenerative care, planned and managed by our team. Legacy brings together stem cell therapy and supportive treatments in one all-inclusive program for adults focused on healthy aging.
You set the goals, we handle the details: scheduling, assessments and follow-up across the year, so you can see how your body changes with clear data at every stage.
A protocol designed for children on the autism spectrum, built with families in mind. Each plan begins with a full evaluation, so our physicians understand the whole health picture before treatment starts.
Families have a dedicated coordinator from the first call through follow-up, and we share openly what current research shows so far.